CLIC News Roundup – September 22, 2020


News Roundup
September 22, 2020

Updates from CLIC


Last Chance to Register!
REGISTRATION CLOSES SEPTEMBER 25, 2020

The CLIC hosted NCATS responsive Un-Meeting has refocused and rescheduled to a ½ day virtual Un-Meeting Wednesday September 30th, 2020. This new “rapid-response” topic will encourage discussions around the changes resulting from the COVID pandemic. Potential themes include

  • Identifying clinical research trial design opportunities as a unified network in the post-COVID clinical era
  • What does training look like?
  • What do remote trials look like?
  • What is the impact on recruitment?
  • What is the role of CTSA Program in clinical research post-COVID?
  • New uses of technology in research?

Other topics to be defined, because, like all of Un-Meetings, the attendees make the agenda!  To keep conversations meaningful, attendance will be limited, so register soon, we are filling up fast! We look forward to seeing you in the ether!


    News from around the CTSA Program Consortium

    Novel Platform Connects Users and Developers of Scientific Vocabularies

    OntoloBridge, a new platform designed to bridge the gap between regular users of controlled scientific vocabularies and the creators of underlying ontologies, has been developed under a collaborative U01 grant by the University of Miami, Stanford University, and Collaborative Drug Discovery.


    The vast majority of Twitter users who vape with JUUL e-cigarettes are not using the devices to stop smoking or to improve their health, according to a research team led by University of Utah Health scientists. The researchers say this finding, which challenges JUUL’s stated mission of improving smokers’ lives, could help hone anti-smoking and vaping efforts targeted at Twitter users, particularly underage teens

    ICYMI: News from the Science & Research World

    The NIH Launches a Global Hunt for Animal-to-Human Diseases

    Centers for Research in Emerging Infectious Diseases), was announced three weeks ago by the National Institute for Allergy and Infectious Diseases within the National Institutes of Health. The NIH is investing $17 million this year and $82 million across five years to create 11 research nodes, mostly at US universities, that will spin up research partnerships in 28 other countries—including China, where the current pandemic began.

    View all posts